GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Asset Turnover

Biotech Growth Trust (The) (LSE:BIOG) Asset Turnover : 0.02 (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Biotech Growth Trust (The)'s Revenue for the six months ended in Sep. 2024 was £9.08 Mil. Biotech Growth Trust (The)'s Total Assets for the quarter that ended in Sep. 2024 was £408.93 Mil. Therefore, Biotech Growth Trust (The)'s Asset Turnover for the quarter that ended in Sep. 2024 was 0.02.

Asset Turnover is linked to ROE % through Du Pont Formula. Biotech Growth Trust (The)'s annualized ROE % for the quarter that ended in Sep. 2024 was 4.53%. It is also linked to ROA % through Du Pont Formula. Biotech Growth Trust (The)'s annualized ROA % for the quarter that ended in Sep. 2024 was 3.97%.


Biotech Growth Trust (The) Asset Turnover Historical Data

The historical data trend for Biotech Growth Trust (The)'s Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Asset Turnover Chart

Biotech Growth Trust (The) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.42 -0.39 -0.10 0.20

Biotech Growth Trust (The) Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 -0.19 -0.04 0.25 0.02

Competitive Comparison of Biotech Growth Trust (The)'s Asset Turnover

For the Asset Management subindustry, Biotech Growth Trust (The)'s Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Growth Trust (The)'s Asset Turnover Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Asset Turnover distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s Asset Turnover falls into.


;
;

Biotech Growth Trust (The) Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Biotech Growth Trust (The)'s Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=77.999/( (360.509+411.42)/ 2 )
=77.999/385.9645
=0.20

Biotech Growth Trust (The)'s Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=9.082/( (411.42+406.442)/ 2 )
=9.082/408.931
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Biotech Growth Trust (The)  (LSE:BIOG) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Biotech Growth Trust (The)'s annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=16.222/357.7115
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(16.222 / 18.164)*(18.164 / 408.931)*(408.931/ 357.7115)
=Net Margin %*Asset Turnover*Equity Multiplier
=89.31 %*0.0444*1.1432
=ROA %*Equity Multiplier
=3.97 %*1.1432
=4.53 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Biotech Growth Trust (The)'s annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=16.222/408.931
=(Net Income / Revenue)*(Revenue / Total Assets)
=(16.222 / 18.164)*(18.164 / 408.931)
=Net Margin %*Asset Turnover
=89.31 %*0.0444
=3.97 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Biotech Growth Trust (The) Asset Turnover Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Growth Trust (The) Business Description

Traded in Other Exchanges
N/A
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. Its performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Biotech Growth Trust (The) Headlines

No Headlines